Meta-analysis of 43 studies (4451 adults with anti-synthetase syndrome): pooled malignancy prevalence was 8.3%. Older age and longer follow-up were associated with malignancy; antibody subtype and clinical features were not significantly associated.
Meta-analysisn = 4,451
Leemans et al. Association between anti-synthetase syndrome and malignancy: a systematic review and meta-analysis